The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer

Journal of Biological Chemistry

Volumn 289, Issue 2, 2014, Pages 1033-1048

  Ronchi, Virginia P ^a   Klein, Jennifer M ^a   Edwards, Daniel J ^a   Haas, Arthur L ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TRANSFORMATION; DEGRADATION SIGNALS; E6-ASSOCIATED PROTEINS; NEURODEVELOPMENT; POLYUBIQUITIN; UBIQUITIN LIGASES;

OLIGOMERIZATION; PROTEINS; TISSUE CULTURE;

OLIGOMERS;

E6 ASSOCIATED PROTEIN; IODINE 125; N ACETYLPHENYLALANYLAMIDE; OLIGOMER; PEPTIDE; POLYUBIQUITIN; PROTEIN E6; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; ARTIFACT; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; HAPPY PUPPET SYNDROME; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; UBE3A GENE;

E3 UBIQUITIN LIGASE; ENZYME KINETICS; ENZYME MECHANISMS; HECT LIGASE; KINETICS; UBIQUITIN;

AMINO ACID SEQUENCE; ANGELMAN SYNDROME; ANIMALS; BINDING SITES; BIOCATALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; HYDROGEN BONDING; IODINE RADIOISOTOPES; ISOENZYMES; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; POLYUBIQUITIN; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SF9 CELLS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84891957449     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.517805     Document Type: Article

References (90)

1. Huibregtse, J. M., Scheffner, M., Beaudenon, S., and Howley, P. M. (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. U.S.A. 92, 2563-2567
2. Rotin, D., and Kumar, S. (2009) Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 10, 398-409
3. Wang, M., and Pickart, C. M. (2005) Different HECT domain ubiquitin ligases employ distinct mechanisms of polyubiquitin chain synthesis. EMBO J. 24, 4324-4333
4. Wang, M., Cheng, D., Peng, J., and Pickart, C. M. (2006) Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase. EMBO J. 25, 1710-1719
5. Beaudenon, S., and Huibregtse, J. M. (2008) HPV E6, E6AP and cervical cancer. BMC Biochem. 9, S4
6. Flashner, B. M., Russo, M. E., Boileau, J. E., Leong, D. W., and Gallicano, G. I. (2013) Epigenetic factors and autism spectrum disorders. Neuromolecular Med. 15, 339-350
7. Nicholls, R. D., and Knepper, J. L. (2001) Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2, 153-175
8. Matentzoglu, K., and Scheffner, M. (2008) Ubiquitin ligase E6-AP and its role in human disease. Biochem. Soc. Trans. 36, 797-801
9. Kishino, T., Lalande, M., and Wagstaff, J. (1997) UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15, 70-73
10. Sutcliffe, J. S., Jiang, Y. H., Galijaard, R. J., Matsuura, T., Fang, P., Kubota, T., Christian, S. L., Bressler, J., Cattanach, B., Ledbetter, D. H., and Beaudet, A. L. (1997) The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Genome Res. 7, 368-377
11. Mabb, A. M., Judson, M. C., Zylka, M. J., and Philpot, B. D. (2011) Angelman syndrome. Insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 34, 293-303
12. Matsuura, T., Sutcliffe, J. S., Fang, P., Galjaard, R. J., Jiang, Y. H., Benton, C. S., Rommens, J. M., and Beaudet, A. L. (1997) De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syn-drome. Nat. Genet. 15, 74-77
13. Lossie, A. C., Whitney, M. M., Amidon, D., Dong, H. J., Chen, P., Theriaque, D., Hutson, A., Nicholls, R. D., Zori, R. T., Williams, C. A., and Driscoll, D. J. (2001) Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J. Med. Genet. 38, 834-845
14. Williams, C. A., Beaudet, A. L., Clayton-Smith, J., Knoll, J. H., Kyllerman, M., Laan, L. A., Magenis, R. E., Moncla, A., Schinzel, A. A., Summers, J. A., and Wagstaff, J. (2006) Angelman syndrome 2005. Updated consensus for diagnostic criteria. Am. J. Med. Genet. A 140, 413-418
15. Clayton-Smith, J., and Laan, L. (2003) Angelman syndrome. A review of the clinical and genetic aspects. J. Med. Genet. 40, 87-95
16. Jiang, Y., Lev-Lehman, E., Bressler, J., Tsai, T. F., and Beaudet, A. L. (1999) Genetics of Angelman syndrome. Am. J. Hum. Genet. 65, 1-6
17. Cooper, E. M., Hudson, A. W., Amos, J., Wagstaff, J., and Howley, P. M. (2004) Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein. J. Biol. Chem. 279, 41208-41217
18. Smith, S. E., Zhou, Y. D., Zhang, G., Jin, Z., Stoppel, D. C., and Anderson, M. P. (2011) Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci. Transl. Med. 3, 103ra97
19. Schaaf, C. P., Sabo, A., Sakai, Y., Crosby, J., Muzny, D., Hawes, A., Lewis, L., Akbar, H., Varghese, R., Boerwinkle, E., Gibbs, R. A., and Zoghbi, H. Y. (2011) Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum. Mol. Genet. 20, 3366-3375
20. Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., Imielinski, M., Frackelton, E. C., Reichert, J., Crawford, E. L., Munson, J., Sleiman, P. M., Chiavacci, R., Annaiah, K., Thomas, K., Hou, C., Glaberson, W., Flory, J., Otieno, F., Garris, M., Soorya, L., Klei, L., Piven, J., Meyer, K. J., Anagnostou, E., Sakurai, T., Game, R. M., Rudd, D. S., Zurawiecki, D., McDougle, C. J., Davis, L. K., Miller, J., Posey, D. J., Michaels, S., Kolevzon, A., Silverman, J. M., Bernier, R., Levy, S. E., Schultz, R. T., Dawson, G., Owley, T., Mc-Mahon, W. M., Wassink, T. H., Sweeney, J. A., Nurnberger, J. I., Coon, H., Sutcliffe, J. S., Minshew, N. J., Grant, S. F., Bucan, M., Cook, E. H., Buxbaum, J. D., Devlin, B., Schellenberg, G. D., and Hakonarson, H. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459, 569-573
21. Samaco, R. C., Hogart, A., and LaSalle, J. M. (2005) Epigenetic overlap in autism-spectrum neurodevelopmental disorders. MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet. 14, 483-492
22. Yashiro, K., Riday, T. T., Condon, K. H., Roberts, A. C., Bernardo, D. R., Prakash, R., Weinberg, R. J., Ehlers, M. D., and Philpot, B. D. (2009) Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 12, 777-783
23. Sato, M., and Stryker, M. P. (2010) Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a. Proc. Natl. Acad. Sci. U.S.A. 107, 5611-5616
24. Huang, H. S., Burns, A. J., Nonneman, R. J., Baker, L. K., Riddick, N. V., Nikolova, V. D., Riday, T. T., Yashiro, K., Philpot, B. D., and Moy, S. S. (2013) Behavioral deficits in an Angelman syndrome model. Effects of genetic background and age. Behav. Brain Res. 243, 79-90
25. Greer, P. L., Hanayama, R., Bloodgood, B. L., Mardinly, A. R., Lipton, D. M., Flavell, S. W., Kim, T. K., Griffith, E. C., Waldon, Z., Maehr, R., Ploegh, H. L., Chowdhury, S., Worley, P. F., Steen, J., and Greenberg, M. E. (2010) The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140, 704-716
26. Margolis, S. S., Salogiannis, J., Lipton, D. M., Mandel-Brehm, C., Wills, Z. P., Mardinly, A. R., Hu, L., Greer, P. L., Bikoff, J. B., Ho, H. Y., Soskis, M. J., Sahin, M., and Greenberg, M. E. (2010) EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell 143, 442-455
27. Gregianin, E., Vazza, G., Scaramel, E., Boaretto, F., Vettori, A., Leonardi, E., Tosatto, S. C., Manara, R., Pegoraro, E., and Mostacciuolo, M. L. (2013) A novel SACS mutation results in non-ataxic spastic paraplegia and peripheral neuropathy. Eur. J. Neurol. 20, 1486-1491
28. Dagli, A., Buiting, K., and Williams, C. A. (2012) Molecular and clinical aspects of Angelman syndrome. Mol. Syndromol. 2, 100-112
29. Philpot, B. D., Thompson, C. E., Franco, L., and Williams, C. A. (2011) Angelman syndrome. Advancing the research frontier of neurodevelopmental disorders. J. Neurodev. Disord. 3, 50-56
30. Kühnle, S., Mothes, B., Matentzoglu, K., and Scheffner, M. (2013) Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc. Proc. Natl. Acad. Sci. U.S.A. 110, 8888-8893
31. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505
32. Huibregtse, J. M., Scheffner, M., and Howley, P. M. (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10, 4129-4135
33. Beer-Romero, P., Glass, S., and Rolfe, M. (1997) Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 14, 595-602
34. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299
35. Talis, A. L., Huibregtse, J. M., and Howley, P. M. (1998) The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J. Biol. Chem. 273, 6439-6445
36. Lawson, J. S., Glenn, W. K., Heng, B., Ye, Y., Tran, B., Lutze-Mann, L., and Whitaker, N. J. (2009) Koilocytes indicate a role for human papilloma virus in breast cancer. Br. J. Cancer 101, 1351-1356
37. Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F., and Iftner, T. (2010) Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Cancer Res. 70, 6913-6924
38. Munakata, T., Liang, Y., Kim, S., McGivern, D. R., Huibregtse, J., Nomoto, A., and Lemon, S. M. (2007) Hepatitis C virus induces E6AP-dependent degradation of the retinoblastoma protein. PLoS Pathog. 3, 1335-1347
39. Shirakura, M., Murakami, K., Ichimura, T., Suzuki, R., Shimoji, T., Fukuda, K., Abe, K., Sato, S., Fukasawa, M., Yamakawa, Y., Nishijima, M., Moriishi, K., Matsuura, Y., Wakita, T., Suzuki, T., Howley, P. M., Miyamura, T., and Shoji, I. (2007) E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J. Virol. 81, 1174-1185
40. Chen, J. J., Hong, Y., Rustamzadeh, E., Baleja, J. D., and Androphy, E. J. (1998) Identification of an-helical motif sufficient for association with papillomavirus E6. J. Biol. Chem. 273, 13537-13544
41. Elston, R. C., Napthine, S., and Doorbar, J. (1998) The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP. J. Gen. Virol. 79, 371-374
42. Be, X., Hong, Y., Wei, J., Androphy, E. J., Chen, J. J., and Baleja, J. D. (2001) Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry 40, 1293-1299
43. Liu, Y., Cherry, J. J., Dineen, J. V., Androphy, E. J., and Baleja, J. D. (2009) Determinants of stability for the E6 protein of papillomavirus type 16. J. Mol. Biol. 386, 1123-1137
44. Zanier, K., Charbonnier, S., Baltzinger, M., Nominé, Y., Altschuh, D., and Travé, G. (2005) Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance. J. Mol. Biol. 349, 401-412
45. Zanier, K., Ruhlmann, C., Melin, F., Masson, M., Ould M'hamed Ould Sidi, A., Bernard, X., Fischer, B., Brino, L., Ristriani, T., Rybin, V., Baltzinger, M., Vande Pol, S., Hellwig, P., Schultz, P., and Travé, G. (2010) E6 proteins from diverse papillomaviruses self-associate both in vitro and in vivo. J. Mol. Biol. 396, 90-104
46. Zanier, K., Charbonnier, S., Sidi, A. O., McEwen, A. G., Ferrario, M. G., Poussin-Courmontagne, P., Cura, V., Brimer, N., Babah, K. O., Ansari, T., Muller, I., Stote, R. H., Cavarelli, J., Vande Pol, S., and Travé, G. (2013) Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science 339, 694-698
47. Nominé, Y., Charbonnier, S., Ristriani, T., Stier, G., Masson, M., Cavusoglu, N., Van Dorsselaer, A., Weiss, E., Kieffer, B., and Travé, G. (2003) Domain substructure of HPV E6 oncoprotein. Biophysical characterization of the E6 C-terminal DNA-binding domain. Biochemistry 42, 4909-4917
48. Kao, W. H., Beaudenon, S. L., Talis, A. L., Huibregtse, J. M., and Howley, P. M. (2000) Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J. Virol. 74, 6408-6417
49. Huang, L., Kinnucan, E., Wang, G., Beaudenon, S., Howley, P. M., Huibregtse, J. M., and Pavletich, N. P. (1999) Structure of an E6AP-UbcH7 complex. Insights into ubiquitination by the E2-E3 enzyme cascade. Science 286, 1321-1326
50. Scheffner, M., Huibregtse, J. M., and Howley, P. M. (1994) Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. U.S.A. 91, 8797-8801
51. Ronchi, V. P., Klein, J. M., and Haas, A. L. (2013) E6AP/UBE3A ubiquitin ligase harbors two E2-ubiquitin binding sites. J. Biol. Chem. 288, 10349-10360
52. Heer, A., Alonso, L. G., and de Prat-Gay, G. (2011) E6*, the 50 amino acid product of the most abundant spliced transcript of the e6 oncoprotein in high-risk human papillomavirus, is a promiscuous folder and binder. Biochemistry 50, 1376-1383
53. Baboshina, O. V., and Haas, A. L. (1996) Novel multiubiquitin chain linkages catalyzed by the conjugating enzymes E2epf and Rad6 are recognized by the 26S proteasome subunit 5. J. Biol. Chem. 271, 2823-2831
54. Haas, A. L. (2005) Purification of E1 and E1-like enzymes. Methods Mol. Biol. 301, 23-35
55. Haas, A. L., and Rose, I. A. (1982) The mechanism of ubiquitin activating enzyme. A kinetic and equilibrium analysis. J. Biol. Chem. 257, 10329-10337
56. Haas, A. L., and Bright, P. M. (1988) The resolution and characterization of putative ubiquitin carrier protein isozymes from rabbit reticulocytes. J. Biol. Chem. 263, 13258-13267
57. Tokgöz, Z., Siepmann, T. J., Streich, F., Jr., Kumar, B., Klein, J. M., and Haas, A. L. (2012) E1-E2 interactions in ubiquitin and Nedd8 ligation pathways. J. Biol. Chem. 287, 311-321
58. Ronchi, V. P., and Haas, A. L. (2012) Measuring rates of ubiquitin chain formation as a functional readout of ligase activity. Methods Mol. Biol. 832, 197-218
59. Siepmann, T. J., Bohnsack, R. N., Tokgöz, Z., Baboshina, O. V., and Haas, A. L. (2003) Protein interactions within the N-end rule ubiquitin ligation pathway. J. Biol. Chem. 278, 9448-9457
60. van Woerden, G. M., Harris, K. D., Hojjati, M. R., Gustin, R. M., Qiu, S., de Avila Freire, R., Jiang, Y. H., Elgersma, Y., and Weeber, E. J. (2007) Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of-CaMKII inhibitory phosphorylation. Nat. Neurosci. 10, 280-282
61. Baboshina, O. V., Crinelli, R., Siepmann, T. J., and Haas, A. L. (2001) N-end rule specificity within the ubiquitin/proteasome pathway is not an affinity effect. J. Biol. Chem. 276, 39428-39437
62. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., and Bates, G. P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548
63. Krissinel, E., and Henrick, K. (2007) Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774-797
64. Maru, Y., Afar, D. E., Witte, O. N., and Shibuya, M. (1996) The dimerization property of glutathione S-transferase partially reactivates Bcr-Abl lacking the oligomerization domain. J. Biol. Chem. 271, 15353-15357
65. Vargo, M. A., Nguyen, L., and Colman, R. F. (2004) Subunit interface residues of glutathione S-transferase A1-1 that are important in the monomer-dimer equilibrium. Biochemistry 43, 3327-3335
66. Huang, Y. C., Misquitta, S., Blond, S. Y., Adams, E., and Colman, R. F. (2008) Catalytically active monomer of glutathione S-transferase-and key residues involved in the electrostatic interaction between subunits. J. Biol. Chem. 283, 32880-32888
67. Levy, E. D., and Teichmann, S. (2013) Structural, evolutionary, and assembly principles of protein oligomerization. Prog. Mol. Biol. Transl. Sci. 117, 25-51
68. Perica, T., Chothia, C., and Teichmann, S. A. (2012) Evolution of oligomeric state through geometric coupling of protein interfaces. Proc. Natl. Acad. Sci. U.S.A. 109, 8127-8132
69. Verdecia, M. A., Joazeiro, C. A., Wells, N. J., Ferrer, J. L., Bowman, M. E., Hunter, T., and Noel, J. P. (2003) Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase. Mol. Cell 11, 249-259
70. Ogunjimi, A. A., Wiesner, S., Briant, D. J., Varelas, X., Sicheri, F., Forman-Kay, J., and Wrana, J. L. (2010) The ubiquitin binding region of the Smurf HECT domain facilitates polyubiquitylation and binding of ubiquitylated substrates. J. Biol. Chem. 285, 6308-6315
71. Pandya, R. K., Partridge, J. R., Love, K. R., Schwartz, T. U., and Ploegh, H. L. (2010)Astructural element within theHUWE1HECT domain modulates self-ubiquitination and substrate ubiquitination activities. J. Biol. Chem. 285, 5664-5673
72. Maspero, E., Mari, S., Valentini, E., Musacchio, A., Fish, A., Pasqualato, S., and Polo, S. (2011) Structure of the HECT:ubiquitin complex and its role in ubiquitin chain elongation. EMBO Rep. 12, 342-349
73. Kamadurai, H. B., Souphron, J., Scott, D. C., Duda, D. M., Miller, D. J., Stringer, D., Piper, R. C., and Schulman, B. A. (2009) Insights into ubiquitin transfer cascades from a structure of a UbcH5B approximately ubiquitin-HECT(NEDD4L) complex. Mol. Cell 36, 1095-1102
74. Ogunjimi, A. A., Briant, D. J., Pece-Barbara, N., Le Roy, C., Di Guglielmo, G. M., Kavsak, P., Rasmussen, R. K., Seet, B. T., Sicheri, F., and Wrana, J. L. (2005) Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol. Cell 19, 297-308
75. Fang, P., Lev-Lehman, E., Tsai, T. F., Matsuura, T., Benton, C. S., Sutcliffe, J. S., Christian, S. L., Kubota, T., Halley, D. J., Meijers-Heijboer, H., Langlois, S., Graham, J. M., Jr., Beuten, J., Willems, P. J., Ledbetter, D. H., and Beaudet, A. L. (1999) The spectrum of mutations in UBE3A causing Angelman syndrome. Hum. Mol. Genet. 8, 129-135
76. Chan, A. L., Grossman, T., Zuckerman, V., Campigli Di Giammartino, D., Moshel, O., Scheffner, M., Monahan, B., Pilling, P., Jiang, Y. H., Haupt, S., Schueler-Furman, O., and Haupt, Y. (2013) C-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activity. Biochemistry 52, 3119-3129
77. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136
78. Huibregtse, J. M., Scheffner, M., and Howley, P. M. (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell Biol. 13, 4918-4927
79. Lagrange, M., Charbonnier, S., Orfanoudakis, G., Robinson, P., Zanier, K., Masson, M., Lutz, Y., Trave, G., Weiss, E., and Deryckere, F. (2005) Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6. J. Gen. Virol. 86, 1001-1007
80. Medcalf, E. A., and Milner, J. (1993) Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620-p53 conformation. Oncogene 8, 2847-2851
81. Thomas, M., Tomaić, V., Pim, D., Myers, M. P., Tommasino, M., and Banks, L. (2013) Interactions between E6AP and E6 proteins from-and-HPV types. Virology 435, 357-362
82. Dai, B., Pieper, R. O., Li, D., Wei, P., Liu, M., Woo, S. Y., Aldape, K. D., Sawaya, R., Xie, K., and Huang, S. (2010) FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes. Cancer Res. 70, 2951-2961
83. Marianayagam, N. J., Sunde, M., and Matthews, J. M. (2004) The power of two. Protein dimerization in biology. Trends Biochem. Sci. 29, 618-625
84. Spitkovsky, D., Aengeneyndt, F., Braspenning, J., and von Knebel Doeberitz, M. (1996) p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Oncogene 13, 1027-1035
85. Streich, F. C., Jr., Ronchi, V. P., Connick, J. P., and Haas, A. L. (2013) TRIM ligases catalyze polyubiquitin chain formation through a cooperative allosteric mechanism. J. Biol. Chem. 288, 8209-8221
86. Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88
87. Kentsis, A., Gordon, R. E., and Borden, K. L. (2002) Control of biochemical reactions through supramolecular RING domain self-assembly. Proc. Natl. Acad. Sci. U.S.A. 99, 15404-15409
88. Sun, L., Deng, L., Ea, C. K., Xia, Z. P., and Chen, Z. J. (2004) The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14, 289-301
89. Wang, X., Herr, R. A., Chua, W. J., Lybarger, L., Wiertz, E. J., and Hansen, T. H. (2007) Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 177, 613-624
90. Page, M. I., and Jencks, W. P. (1971) Entropic contributions to rate accelerations in enzymic and intramolecular reactions and the chelate effect. Proc. Natl. Acad. Sci. U.S.A. 68, 1678-1683